User profiles for Delphine Planas
DELPHINE PLANASPasteur Institut Verified email at pasteur.fr Cited by 6974 |
[HTML][HTML] Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
D Planas, D Veyer, A Baidaliuk, I Staropoli… - Nature, 2021 - nature.com
The SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India 1 , 2 , 3 , 4 – 5 .
Since then, it has become dominant in some regions of India and in the UK, and has spread to …
Since then, it has become dominant in some regions of India and in the UK, and has spread to …
[HTML][HTML] Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
D Planas, N Saunders, P Maes, F Guivel-Benhassine… - Nature, 2022 - nature.com
The SARS-CoV-2 Omicron variant was first identified in November 2021 in Botswana and
South Africa 1 , 2 – 3 . It has since spread to many countries and is expected to rapidly become …
South Africa 1 , 2 – 3 . It has since spread to many countries and is expected to rapidly become …
[HTML][HTML] Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.7 and B.1.351 variants
were first identified in the United Kingdom and South Africa, respectively, and have since …
were first identified in the United Kingdom and South Africa, respectively, and have since …
[HTML][HTML] Serum neutralization of SARS-CoV-2 Omicron sublineages BA. 1 and BA. 2 in patients receiving monoclonal antibodies
The severe acute respiratory syndrome coronavirus 2 Omicron BA.1 sublineage has been
supplanted in many countries by the BA.2 sublineage. BA.2 differs from BA.1 by about 21 …
supplanted in many countries by the BA.2 sublineage. BA.2 differs from BA.1 by about 21 …
[HTML][HTML] Resistance of Omicron subvariants BA. 2.75. 2, BA. 4.6, and BQ. 1.1 to neutralizing antibodies
Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 lineages has led to the
emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The …
emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The …
Syncytia formation by SARS‐CoV‐2‐infected cells
Severe cases of COVID‐19 are associated with extensive lung damage and the presence of
infected multinucleated syncytial pneumocytes. The viral and cellular mechanisms …
infected multinucleated syncytial pneumocytes. The viral and cellular mechanisms …
[HTML][HTML] Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection
Background Assessment of the kinetics of SARS-CoV-2 antibodies is essential in predicting
risk of reinfection and durability of vaccine protection. Methods This is a prospective, …
risk of reinfection and durability of vaccine protection. Methods This is a prospective, …
A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
It is of paramount importance to evaluate the prevalence of both asymptomatic and symptomatic
cases of SARS-CoV-2 infection and their differing antibody response profiles. Here, we …
cases of SARS-CoV-2 infection and their differing antibody response profiles. Here, we …
[HTML][HTML] Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
…, V Leducq, K Zafilaza, D Sterlin, D Planas… - Nature …, 2021 - nature.com
There are only few data concerning persistence of neutralizing antibodies (NAbs) among
SARS-CoV-2-infected healthcare workers (HCW). These individuals are particularly exposed …
SARS-CoV-2-infected healthcare workers (HCW). These individuals are particularly exposed …
SARS‐CoV‐2 Alpha, Beta, and Delta variants display enhanced Spike‐mediated syncytia formation
Severe COVID‐19 is characterized by lung abnormalities, including the presence of syncytial
pneumocytes. Syncytia form when SARS‐CoV‐2 spike protein expressed on the surface of …
pneumocytes. Syncytia form when SARS‐CoV‐2 spike protein expressed on the surface of …